Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin

J. S. Floras, Phil Aylward, F. M. Abboud, A. L. Mark

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Arginine vasopressin, a potent vasoconstrictor, does not raise arterial pressure in normal humans even at pathophysiological plasma levels. To examine whether the pressor effect of vasopressin in humans is buffered by baroreceptor reflex inhibition of sympathetic nerve activity, we recorded postganglionic muscle sympathetic nerve activity directly from the peroneal nerve in 12 normal men before, during, and after a 20-minute intravenous infusion of vasopressin, 4 ng/kg/min, that increased mean plasma concentrations from 6.2 ± 0.6 to 320 ± 68 (SE) pg/ml. During the first 5 minutes (n = 8), mean arterial pressure increased from 91 ± 3 to 97 ± 4 mm Hg (p<0.05) and integrated sympathetic nerve activity decreased from 271 ± 45 to 156 ± 33 units (p<0.05). At 15 minutes (n = 12), arterial pressure dit not differ from control values whereas forearm vascular resistance fell (p<0.05) and central venous pressure and heart rate increased (p<0.05). Sympathetic nerve activity remained below control levels throughout the infusion (202 ± 31 vs 254 ± 40 units before infusion; p<0.05). An effect of vasopressin on ganglionic transmission was excluded, since the sympathoexcitatory response to apnea was not attenuated during vasopressin. Thus, pathophysiologic levels of vasopressin in humans cause inhibition of muscle sympathetic nerve activity that is not due to a ganglionic blocking action. The sympathoinhibition may be caused in part by the modest increases in mean arterial and central venous pressures and attendant stimulation of arterial and cardiac baroreceptors. The reflex decrease in sympathetic nerve activity would be expected to buffer the direct vasoconstrictor effects of vasopressin.

LanguageEnglish
Pages409-416
Number of pages8
JournalHypertension
Volume10
Issue number4
DOIs
Publication statusPublished - 1 Jan 1987

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Floras, J. S. ; Aylward, Phil ; Abboud, F. M. ; Mark, A. L. / Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin. In: Hypertension. 1987 ; Vol. 10, No. 4. pp. 409-416.
@article{6a8f490ab0874b32a374ffe53ccb60db,
title = "Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin",
abstract = "Arginine vasopressin, a potent vasoconstrictor, does not raise arterial pressure in normal humans even at pathophysiological plasma levels. To examine whether the pressor effect of vasopressin in humans is buffered by baroreceptor reflex inhibition of sympathetic nerve activity, we recorded postganglionic muscle sympathetic nerve activity directly from the peroneal nerve in 12 normal men before, during, and after a 20-minute intravenous infusion of vasopressin, 4 ng/kg/min, that increased mean plasma concentrations from 6.2 ± 0.6 to 320 ± 68 (SE) pg/ml. During the first 5 minutes (n = 8), mean arterial pressure increased from 91 ± 3 to 97 ± 4 mm Hg (p<0.05) and integrated sympathetic nerve activity decreased from 271 ± 45 to 156 ± 33 units (p<0.05). At 15 minutes (n = 12), arterial pressure dit not differ from control values whereas forearm vascular resistance fell (p<0.05) and central venous pressure and heart rate increased (p<0.05). Sympathetic nerve activity remained below control levels throughout the infusion (202 ± 31 vs 254 ± 40 units before infusion; p<0.05). An effect of vasopressin on ganglionic transmission was excluded, since the sympathoexcitatory response to apnea was not attenuated during vasopressin. Thus, pathophysiologic levels of vasopressin in humans cause inhibition of muscle sympathetic nerve activity that is not due to a ganglionic blocking action. The sympathoinhibition may be caused in part by the modest increases in mean arterial and central venous pressures and attendant stimulation of arterial and cardiac baroreceptors. The reflex decrease in sympathetic nerve activity would be expected to buffer the direct vasoconstrictor effects of vasopressin.",
author = "Floras, {J. S.} and Phil Aylward and Abboud, {F. M.} and Mark, {A. L.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1161/01.HYP.10.4.409",
language = "English",
volume = "10",
pages = "409--416",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin. / Floras, J. S.; Aylward, Phil; Abboud, F. M.; Mark, A. L.

In: Hypertension, Vol. 10, No. 4, 01.01.1987, p. 409-416.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin

AU - Floras, J. S.

AU - Aylward, Phil

AU - Abboud, F. M.

AU - Mark, A. L.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Arginine vasopressin, a potent vasoconstrictor, does not raise arterial pressure in normal humans even at pathophysiological plasma levels. To examine whether the pressor effect of vasopressin in humans is buffered by baroreceptor reflex inhibition of sympathetic nerve activity, we recorded postganglionic muscle sympathetic nerve activity directly from the peroneal nerve in 12 normal men before, during, and after a 20-minute intravenous infusion of vasopressin, 4 ng/kg/min, that increased mean plasma concentrations from 6.2 ± 0.6 to 320 ± 68 (SE) pg/ml. During the first 5 minutes (n = 8), mean arterial pressure increased from 91 ± 3 to 97 ± 4 mm Hg (p<0.05) and integrated sympathetic nerve activity decreased from 271 ± 45 to 156 ± 33 units (p<0.05). At 15 minutes (n = 12), arterial pressure dit not differ from control values whereas forearm vascular resistance fell (p<0.05) and central venous pressure and heart rate increased (p<0.05). Sympathetic nerve activity remained below control levels throughout the infusion (202 ± 31 vs 254 ± 40 units before infusion; p<0.05). An effect of vasopressin on ganglionic transmission was excluded, since the sympathoexcitatory response to apnea was not attenuated during vasopressin. Thus, pathophysiologic levels of vasopressin in humans cause inhibition of muscle sympathetic nerve activity that is not due to a ganglionic blocking action. The sympathoinhibition may be caused in part by the modest increases in mean arterial and central venous pressures and attendant stimulation of arterial and cardiac baroreceptors. The reflex decrease in sympathetic nerve activity would be expected to buffer the direct vasoconstrictor effects of vasopressin.

AB - Arginine vasopressin, a potent vasoconstrictor, does not raise arterial pressure in normal humans even at pathophysiological plasma levels. To examine whether the pressor effect of vasopressin in humans is buffered by baroreceptor reflex inhibition of sympathetic nerve activity, we recorded postganglionic muscle sympathetic nerve activity directly from the peroneal nerve in 12 normal men before, during, and after a 20-minute intravenous infusion of vasopressin, 4 ng/kg/min, that increased mean plasma concentrations from 6.2 ± 0.6 to 320 ± 68 (SE) pg/ml. During the first 5 minutes (n = 8), mean arterial pressure increased from 91 ± 3 to 97 ± 4 mm Hg (p<0.05) and integrated sympathetic nerve activity decreased from 271 ± 45 to 156 ± 33 units (p<0.05). At 15 minutes (n = 12), arterial pressure dit not differ from control values whereas forearm vascular resistance fell (p<0.05) and central venous pressure and heart rate increased (p<0.05). Sympathetic nerve activity remained below control levels throughout the infusion (202 ± 31 vs 254 ± 40 units before infusion; p<0.05). An effect of vasopressin on ganglionic transmission was excluded, since the sympathoexcitatory response to apnea was not attenuated during vasopressin. Thus, pathophysiologic levels of vasopressin in humans cause inhibition of muscle sympathetic nerve activity that is not due to a ganglionic blocking action. The sympathoinhibition may be caused in part by the modest increases in mean arterial and central venous pressures and attendant stimulation of arterial and cardiac baroreceptors. The reflex decrease in sympathetic nerve activity would be expected to buffer the direct vasoconstrictor effects of vasopressin.

UR - http://www.scopus.com/inward/record.url?scp=0023625804&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.10.4.409

DO - 10.1161/01.HYP.10.4.409

M3 - Article

VL - 10

SP - 409

EP - 416

JO - Hypertension

T2 - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -